EUVIMEDEUVIMED entdecken
Multizentrische Studie

Transcatheter Tricuspid Valve Replacement in Patients With Cardiac Implantable Electronic Device Leads

Bryan P Traynor, Andrea Scotti, Rishi Puri, Matteo Sturla, Firas Zahr, Robert Boone, Susheel Kodali, Didier Tchétché, Ole De Backer, Augustin Coisne, Sebastian Ludwig, Lukas Stolz und 31 weitere

JACC: Clinical Electrophysiology · 2026-03 · 12 (3) · 474-485

DOI: 10.1016/j.jacep.2025.12.027 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2026-03. Verfasst von Bryan P Traynor und 42 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Structural Heart Program, St Michael's Hospital, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Tricuspid Valve, Heart Valve Prosthesis Implantation, Defibrillators, Implantable. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients undergoing orthotopic transcatheter tricuspid valve replacement (TTVR) frequently present with a cardiac implantable electronic device (CIED) lead traversing the tricuspid valve. OBJECTIVES: This study sought to investigate the clinical, procedural, and lead-related outcomes of orthotopic TTVR in patients with transvalvular CIED leads. METHODS: All consecutive patients enrolled in the multicenter TRIPLACE (Global Multicenter Registry on Transcatheter Tricuspid Valve Replacement) registry were included for analysis. Patients were stratified based on the presence of a CIED lead traversing the tricuspid valve. Changes in lead function parameters were assessed after TTVR in a subset of these patients who had pacemaker lead parameter data recorded. Lead failure was defined as structural or electrical malfunction requiring new lead or CIED insertion. RESULTS: Among 395 patients, 104 (26.3%) had transvalvular CIED leads. Procedural success, symptomatic improvement, and 30-day mortality were comparable between those with and without CIED. Patients with CIED leads had lower rates of mild or less residual tricuspid regurgitation (82.6% vs 91.4%; P < 0.041) and higher rates of moderate or greater paravalvular leak (17.1% vs 7.1%; P < 0.017). Lead failure occurred in 5.8% over a median follow-up time of 183 days, with modest changes in pacing thresholds. No significant increase in adverse events or mortality was observed at 30 days. CONCLUSIONS: Orthotopic TTVR in patients with transvalvular CIED leads can be safely and effectively performed with low rates of lead failure. Significant paravalvular leak and residual tricuspid regurgitation is more common with a jailed lead. These patients require close CIED follow-up with alternative pacing strategies in place, particularly when pacing dependent. (Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment [TRIPLACE]; NCT06033274).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pacemaker, ArtificialTricuspid ValveHeart Valve Prosthesis ImplantationDefibrillators, ImplantableHumansFemaleRegistriesMaleAgedTricuspid Valve InsufficiencyAged, 80 and overTreatment Outcome

Stichwörter der Autor:innen

cardiac implantable electronic devicelead failurepacemakertranscatheter tricuspid valve replacementtricuspid regurgitation

Autor:innen und Institutionen

  • Division of Cardiology, Structural Heart Program, St Michael's Hospital, Toronto, Ontario, Canada.
  • Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Oregon Health and Science University, Portland, Oregon, USA.
  • Centre for Heart Valve Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Division of Cardiology, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York, New York, USA.

Zitieren

APA

Traynor, B. P., Scotti, A., Puri, R., Sturla, M., Zahr, F., Boone, R., Kodali, S., Tchétché, D., De Backer, O., Coisne, A., Ludwig, S., Stolz, L., Loureiro, R. E., Adam, M., De Marco, F., Biroli, M., Ho, E. C., Cheung, A., Patrascu, A., …, & Fam, N. (2026). Transcatheter Tricuspid Valve Replacement in Patients With Cardiac Implantable Electronic Device Leads. JACC: Clinical Electrophysiology, 12(3), 474-485. https://doi.org/10.1016/j.jacep.2025.12.027

Vancouver

Traynor BP, Scotti A, Puri R, Sturla M, Zahr F, Boone R, et al. Transcatheter Tricuspid Valve Replacement in Patients With Cardiac Implantable Electronic Device Leads. JACC: Clinical Electrophysiology. 2026;12(3):474-485. doi:10.1016/j.jacep.2025.12.027

BibTeX
@article{Traynor2026,
  author = {Traynor, Bryan P and Scotti, Andrea and Puri, Rishi and Sturla, Matteo and Zahr, Firas and Boone, Robert and Kodali, Susheel and Tchétché, Didier and De Backer, Ole and Coisne, Augustin and Ludwig, Sebastian and Stolz, Lukas and Loureiro, Rodrigo Estévez and Adam, Matti and De Marco, Federico and Biroli, Matteo and Ho, Edwin C and Cheung, Anson and Patrascu, Alexandru and Alnasser, Sami and Chadderdon, Scott and Lulic, Davorka and Bartkowiak, Joanna and Echarte-Morales, Julio and Sievert, Horst and Byrne, Timothy and Maisano, Francesco and Frerker, Christian and Dumonteil, Nicolas and Oliva, Omar A and Rudolph, Tanja K and Rudolph, Felix and Krishnaswamy, Amar and Kapadia, Samir R and Portillo, Juan Del and Rodés-Cabau, Josep and Schofer, Niklas and Granada, Juan F and Hausleiter, Jörg and Hahn, Rebecca T and Modine, Thomas and Latib, Azeem and Fam, Neil},
  title = {Transcatheter Tricuspid Valve Replacement in Patients With Cardiac Implantable Electronic Device Leads},
  journal = {JACC: Clinical Electrophysiology},
  year = {2026},
  volume = {12},
  number = {3},
  pages = {474--485},
  doi = {10.1016/j.jacep.2025.12.027}
}
Kostenlos starten →